BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

855 related articles for article (PubMed ID: 19723115)

  • 1. Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells.
    Kim SH; Song YC; Kim SH; Jo H; Song YS
    Ann N Y Acad Sci; 2009 Aug; 1171():642-8. PubMed ID: 19723115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitogen-activated protein kinase phosphatase-1 modulated JNK activation is critical for apoptosis induced by inhibitor of epidermal growth factor receptor-tyrosine kinase.
    Takeuchi K; Shin-ya T; Nishio K; Ito F
    FEBS J; 2009 Mar; 276(5):1255-65. PubMed ID: 19175673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of EGFR and ErbB2 by the novel dual EGFR and ErbB2 tyrosine kinase inhibitor GW572016 sensitizes human colon carcinoma GEO cells to apoptosis.
    Zhou Y; Li S; Hu YP; Wang J; Hauser J; Conway AN; Vinci MA; Humphrey L; Zborowska E; Willson JK; Brattain MG
    Cancer Res; 2006 Jan; 66(1):404-11. PubMed ID: 16397255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of combining epidermal growth factor receptor inhibitors and cisplatin on proliferation and apoptosis of oral squamous cell carcinoma cells.
    Takaoka S; Iwase M; Uchida M; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M; Shintani S
    Int J Oncol; 2007 Jun; 30(6):1469-76. PubMed ID: 17487368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrphostin AG1478 suppresses proliferation and invasion of human breast cancer cells.
    Zhang YG; Du Q; Fang WG; Jin ML; Tian XX
    Int J Oncol; 2008 Sep; 33(3):595-602. PubMed ID: 18695891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy of epidermal growth factor receptor kinase inhibitor AG1478 and ErbB2 kinase inhibitor AG879 in human colon carcinoma cells is associated with induction of apoptosis.
    Zhou Y; Brattain MG
    Cancer Res; 2005 Jul; 65(13):5848-56. PubMed ID: 15994962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celecoxib potentiates the anticancer effect of cisplatin on vulvar cancer cells independently of cyclooxygenase.
    Kim SH; Kim SH; Song YC; Song YS
    Ann N Y Acad Sci; 2009 Aug; 1171():635-41. PubMed ID: 19723114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-targeting the EGFR and IGF-IR with anti-EGFR monoclonal antibody ICR62 and the IGF-IR tyrosine kinase inhibitor NVP-AEW541 in colorectal cancer cells.
    Cunningham MP; Thomas H; Marks C; Green M; Fan Z; Modjtahedi H
    Int J Oncol; 2008 Nov; 33(5):1107-13. PubMed ID: 18949375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Src tyrosine kinase inhibitor PP2 suppresses ERK1/2 activation and epidermal growth factor receptor transactivation by X-irradiation.
    Li Z; Hosoi Y; Cai K; Tanno Y; Matsumoto Y; Enomoto A; Morita A; Nakagawa K; Miyagawa K
    Biochem Biophys Res Commun; 2006 Mar; 341(2):363-8. PubMed ID: 16414009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinoma.
    Liu Y; Poon RT; Shao W; Sun X; Chen H; Kok TW; Fan ST
    Cancer Lett; 2007 Apr; 248(1):32-40. PubMed ID: 16837130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of catalase increases malignant mouse keratinocyte cell growth through activation of the stress activated JNK pathway.
    Hanke NT; Finch JS; Bowden GT
    Mol Carcinog; 2008 May; 47(5):349-60. PubMed ID: 17935202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor is involved in clusterin-induced astrocyte proliferation.
    Shim YJ; Shin YJ; Jeong SY; Kang SW; Kim BM; Park IS; Min BH
    Neuroreport; 2009 Mar; 20(4):435-9. PubMed ID: 19218870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells.
    Ota H; Tokunaga E; Chang K; Hikasa M; Iijima K; Eto M; Kozaki K; Akishita M; Ouchi Y; Kaneki M
    Oncogene; 2006 Jan; 25(2):176-85. PubMed ID: 16170353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways.
    Park CM; Park MJ; Kwak HJ; Lee HC; Kim MS; Lee SH; Park IC; Rhee CH; Hong SI
    Cancer Res; 2006 Sep; 66(17):8511-9. PubMed ID: 16951163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel and ceramide synergistically induce cell death with transient activation of EGFR and ERK pathway in pancreatic cancer cells.
    Qiu L; Zhou C; Sun Y; Di W; Scheffler E; Healey S; Wanebo H; Kouttab N; Chu W; Wan Y
    Oncol Rep; 2006 Oct; 16(4):907-13. PubMed ID: 16969513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrphostin AG825 triggers p38 mitogen-activated protein kinase-dependent apoptosis in androgen-independent prostate cancer cells C4 and C4-2.
    Murillo H; Schmidt LJ; Tindall DJ
    Cancer Res; 2001 Oct; 61(20):7408-12. PubMed ID: 11606371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor lacking C-terminal autophosphorylation sites retains signal transduction and high sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor.
    Maegawa M; Arao T; Yokote H; Matsumoto K; Kudo K; Tanaka K; Kaneda H; Fujita Y; Ito F; Nishio K
    Cancer Sci; 2009 Mar; 100(3):552-7. PubMed ID: 19154417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-I (IGF-I) induces epidermal growth factor receptor transactivation and cell proliferation through reactive oxygen species.
    Meng D; Shi X; Jiang BH; Fang J
    Free Radic Biol Med; 2007 Jun; 42(11):1651-60. PubMed ID: 17462533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic targeting of EGFR does not predict the treatment outcome in combination with the EGFR tyrosine kinase inhibitor Tyrphostin AG1478.
    Weyergang A; Kaalhus O; Berg K
    Photochem Photobiol Sci; 2008 Sep; 7(9):1032-40. PubMed ID: 18754049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.